- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Durvalumab (MEDI4736)
Total 738 results
-
AstraZenecaParexelRecruitingNon-small Cell Lung CancerHungary, United States, Italy, Belgium, Spain, France, Korea, Republic of, Taiwan, Turkey, Ireland, Portugal, Canada
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerPoland, India, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Hungary, Japan, Mexico, Peru, Philippines, Russian Federation
-
CelgeneCompletedLymphoma | Leukemia, Lymphocytic, Chronic, B-CellUnited States, United Kingdom, Germany, France, Italy, Netherlands, Japan
-
M.D. Anderson Cancer CenterNektar TherapeuticsRecruitingLung CancerUnited States
-
University of Alabama at BirminghamUnited States Department of DefenseNot yet recruitingSarcoma | NF1 | MPNSTUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
University College, LondonAstraZeneca; Cancer Research UK; Kidney Cancer UKRecruiting
-
Memorial Sloan Kettering Cancer CenterCompletedEndometrial Cancer | Endometrial Carcinoma | Endometrial Carcinosarcoma | Endometrial Cancer Recurrent | Endometrial Carcinoma, RecurrentUnited States
-
M.D. Anderson Cancer CenterAstraZeneca; Mirati Therapeutics Inc.WithdrawnLung Cancer | Gastro-intestinal CancerUnited States
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Gustave Roussy, Cancer Campus, Grand ParisWithdrawnMetastatic Colorectal Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Prostate Adenocarcinoma | Stomach Adenocarcinoma
-
Institut Català d'OncologiaAstraZeneca; BioClever 2005 S.L.; VCN Biosciences, S.L.Active, not recruitingRecurrence | Head and Neck Neoplasms | Metastasis | Carcinoma, Squamous Cell of Head and NeckSpain
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
European Organisation for Research and Treatment...WithdrawnSquamous Non-small Cell Lung Cancer | Non-Squamous Non-small Cell Lung Cancer
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
Peking Union Medical College HospitalRecruitingGastrointestinal Neuroendocrine CarcinomaChina
-
Seoul National University HospitalChungnam National University Hospital; Korean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of
-
University Health Network, TorontoRecruiting
-
M.D. Anderson Cancer CenterMedImmune LLCActive, not recruitingAdvanced and/or Metastatic SarcomaUnited States
-
Alliance Foundation Trials, LLC.AstraZenecaActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung CancerUnited States
-
AstraZenecaApproved for marketing
-
UNICANCERAstraZeneca; National Cancer Institute, France; Pierre Fabre LaboratoriesActive, not recruitingBreast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid TumoursFrance
-
National Cancer Institute, NaplesRecruiting
-
Institut BergoniéEpizyme, Inc.; AstraZenecaRecruitingAdult Solid Tumor | Advanced Solid Tumor | Advanced Pancreatic Adenocarcinoma | Advanced Colorectal Carcinoma | Advanced Soft-tissue SarcomaFrance
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedBreast Cancer | Triple Negative Breast Cancer | Luminal BBelgium
-
MedImmune LLCCompletedCarcinoma | Metastatic Pancreatic AdenocarcinomaUnited States, Spain, Australia, Norway
-
AstraZenecaCompletedAdvanced Solid Malignancies | Non-Small Cell Lung Cancer (NSCLC) | Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC) | Colorectal Carcinoma (CRC)United States
-
University of Alabama at BirminghamTerminatedCholangiocarcinomaUnited States
-
Boston Scientific CorporationBiocompatibles UK LtdRecruitingHepatocellular CarcinomaUnited States, Spain, France
-
Second Affiliated Hospital, School of Medicine,...Completed
-
University Health Network, TorontoClinica Universidad de Navarra, Universidad de Navarra; University of MilanRecruitingHepatocellular CarcinomaSpain, Canada, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingBladder CarcinomaItaly
-
AstraZenecaActive, not recruitingGastrointestinal Neoplasms | Esophagogastric JunctionBelgium, Denmark, Spain, United Kingdom, Canada, United States, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, Hungary, Japan, Peru, Poland, Russian Federation, Netherlands, Chile, Argentina
-
Zhonglin HaoBayerActive, not recruiting
-
University of Colorado, DenverAstraZenecaWithdrawn
-
Muhammad FurqanRecruitingNon-small Cell Lung CancerUnited States
-
AstraZenecaRecruitingAdvanced Hepatocellular CarcinomaKorea, Republic of, Italy, Spain, Vietnam, Germany, France, Japan, United States, Hong Kong, Singapore
-
Washington University School of MedicineAstraZenecaRecruitingPrimary Central Nervous System LymphomaUnited States
-
Massachusetts General HospitalAstraZenecaRecruitingHepatocellular Carcinoma | Biliary Tract CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Van Andel Research InstituteActive, not recruitingUnresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | Recurrent Gallbladder Carcinoma | Unresectable Gallbladder Carcinoma | Recurrent Hepatocellular Carcinoma and other conditionsUnited States
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingOropharyngeal Squamous Cell CarcinomaCanada, Spain, Belgium, Italy
-
Baptist Health South FloridaAstraZenecaTerminatedAdenocarcinoma of the PancreasUnited States
-
Shanghai First Maternity and Infant HospitalUnknown
-
MultiVir, Inc.UnknownLymphoma | Solid TumorUnited States
-
Baylor College of MedicineDuke Cancer InstituteNot yet recruitingMesotheliomaUnited States
-
University Health Network, TorontoOICRNot yet recruitingNon-Small Cell Lung Cancer (NSCLC) | Clinical Staging T2b-3 N0-1 M0
-
The University of Hong KongRecruiting
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingNSCLC | Lung Cancer | Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | PD-L1 Gene Mutation | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIUnited States
-
Michael HoppAstraZenecaRecruitingSmall Cell Lung Cancer Limited StageGermany